{"ticker": {"uuid": "d66f17b1-6450-4ef3-badc-733d31fbf551", "symbol": "REGN34", "name": "Regeneron Pharmaceuticals, Inc.", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Cantor Fitzgerald reiterates Overweight on Regeneron stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQY3BSUG9mVG1DemtqN3h0UnNDWVhjZmlXbmpMTmJTejNNR2Q0YnZadlJadUVueHZZcGQ0bElZUnNCd3ZMU1UzbGlGVC1hd0FJRlFkMEVWVkFPbHJ2SlU5Xy1rTHBMV3FuU2hfZnBheHBja3Jpc2E0T1hjSnJ5MlZKLS0xbXE5QnJPMDhrWllKaHRRM1BPRGxCRXRlV0VpX2FOT3VkVmFFMnN5OE1xQW52MXJKVlN1clJXY2c?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T12:38:02+00:00", "published_display": "13 Jul 2026 12:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines closes $770.5m IPO, Regeneron investment By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPU0tSSk1jMzJOYU9ZUHQyaGRfUjR6OVJEaWlxUHBadXFFOXAxQ0RQTGZyM24wVExXS1A2dHhJUEdMNU5GekMyWXRwY1ZqSUpPcG94bS1yNkRvTUJMMGlqMFFzckZ1T1E0N1g5czV1NnpLaGlpZ29qN05PQVp1RDJrVWZpVU5EaTA1Uk53WTRVVE0zcE9Lb0NMUl9jTVpLdlVCM3FqREpKamZyNWJQdzMyWC03cnY?oc=5", "source_name": "Investing.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals Stock Underperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOX21uNnozSGduQ1M3QlRrWWNxZnZlWG1jMGRqOWtQZzUwcUhtZk5BOV9KWWQ0MFBXUG9NX0ZhSnF6TVd5OVktZmpOTUJqeUhFanNZYkpIYmdHY2Z1V3RLT3JOM21LUE1CU2xkZjJGcjViVzJ6MzBCLXdRekVYTjdoa0U2RlBOc1pLSmRfT1l5RDRfSVBVOEJPWWVwbDMyeFdMVkV6Mg?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxPaElEUnNfMXZSWlNUNHpSQzItbUJjY3I3M3lSSXc1LV8zLWpjcWY0Xzl3WjBmZUp4RThrdDRDZnNMc3JFNTJ4QWpHZHd3ZlRIcHpqTDNlRUZNNldfcWRJQi1yOGltZl9qSFdwcUNJT2p1NmlVQWdmNmQ5RUhIY3g4NERESVdkaV9CSUFjYUNVeDFxaG1CYnJzNFpDanFDb0E2NUFYS1VWYTFVWlhIVWhJOU1ma1hhclNocERGdDJnRjl6dEhkbGdlM2NPa1IzZnc3VDFJbGpaZXdSUlpJNDFzN2hIajVLcUFVQVg1cVZjQjg0eWN3eUdKbGN4TzlaVnU1WEE?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOeE1fSzB4M1VyMGNuay1rc1lEaDFBV19SS2dCZjFPdnpKX3RDSUFNM0tYdFdicXFXMVFmdFZyNmdYWjFfUTJ5T2M2SDlfSUdCQ3llMXNlSVZfeXFjNG05RnFRcmdsZ0NaV3ZUTlFnNl9DU2dqYVY3OS1SbGl2a0FKTW1rSFkyQjJlSFY1Y1c3anBNSnhIYktMR1NIdzFOam1HTzJxSmJuS2tQNG00R1Y0T1hKbG9MR3FCYTdwRW9NWi1rQzhTaWVMMVR3?oc=5", "source_name": "Barchart.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOdFFtWjBqUUZtY1JKVHVJczNUV0VsaUNsckR3cXY3SnlDbWlidlkzZ1RwNmR2LVpMM1FvdjZra2tvNVptS3JobG0zN0VvaHludjYtaW9waFplcHNXY0pCRFlpZ1NERWZjMjQwZUVJSWIydWlPZDZ6cEM1RkVlUmR5TDRUdmxmWWVOV3BXUkNVSWVyT050b09aRHFWWUF3d3hwTnVfYjUtYU8wM19pel9qTXVrTmhXaE5GU2FQeHVveldOVTdC?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron shares slide despite Q1 beat", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNSmUwR1RzVHZWRm01cUFQVGhJNU9EbDBIbHBvdDQyaUl1Z2lVSWtXZENKdWxpUHN5X1Q2bGM3VXkyS3lCcUZQRlZkRFFhSkhCMnJpLWFJQXNkYUhwaUlSdUdrNlN1ckdSbWtSSzNHanh6MGFKQWd2SDZudWxkclA5X0doU2tzd3h0ZjBvdzdEd240VzRib25SeVVsVHNfdlFJYWlPRjhfcXNFSWNvanc?oc=5", "source_name": "Proactive financial news", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Regeneron Q1 2026 beats estimates, stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNbW50aG5rWjFnY1Roa3ZuRTBnVDdnX2R4MjhnVU5Wc2VFX2JOX3dLLVBPOUFTbmxCOVBCdEluM1VfcFRFX05EUF9Nd3JsWVUzbVd1N3c1NE1Ma05JQkZIcklscExmaVRFTXRHME1sdTU3ZWhvU0xVdS1SZDgwVmoyT2E2Ui1iSUUwNHFIQ2haXzNza0luT2d2cmhRalh4RFpRcG5pY0Q3M2JvX2ZMcXoxcUlyYkFKNzE0dG1jMkVNR2oxNGc?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bernstein SocGen lowers Regeneron stock price target to $913", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQaEs3ZDdjaUZlUGpIbVZQQi1TNWpmeEhmRnRZSllTYnZJS0QxZ0luMmdlbmsydmYtdTJUeUpqTk1DX3Fnd2Q2YnE5THRoWlRuSWZBX3RmRG1razZxYnlmRzI3SUdEbWRCblhjZmhUUWNkb200WVFxa3ljTFBiTmYyZWxScjNac0h0OHFXUm9EcjVrT2NPMXA2UzhrQkhIT0hJMFFkZVFtRjJ1R0Rqd2VsMmNHLTI0c0dNTGVN?oc=5", "source_name": "Investing.com", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron wins FDA approval for first gene therapy for genetic hearing loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQRXRkLU93ajlCYTBxa1JQQ1RYdTZJVXBDNmpBcTNNYzBFYWthTzExNFN1b09DUTZSYWxNN19vQzFxREZzOXoydzhjd2dQd0ZONS03NHRaZVZyLUhxNXhMbnJYVUhyRW5YNmFIUnloNDdTOEpZdnNHTkZLZktxNHpwZ2ZyMklqWkxkOW93UWFTVlpnLXZWSjB0elNTdnZqMmoyVDMwUVFoZm1ZTVY3a3dOWXA4Q0lQVVUxYTVwM1RXc1dvSkxwX2c?oc=5", "source_name": "Reuters", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron and Telix Announce Strategic Radiopharma Collaboration", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQN3p0TC1TbVVxOTE5Vm5ZQ2FmU2plWktUencybFRzcG5oSm5leFloVWJvSk5ORzcxLWNqNWo2VUlsd24yNk9rQlZHeXBsSHJ6bWJacUJhM2VhcENaeGxEZnY5aHEtQlB0a3lWT242a3o2Z0V1REhqT2RWeHNqMHRiZXl1UW1SSmxrN2txLTdtalBzUkwwRlVkWWVzanQ4S2ZyWnVmQ3pUNmNuejd4RE1Zd0FuaERCVUl1bjE0Umd1b3FNcV9BUGFKTmJjVQ?oc=5", "source_name": "Regeneron", "published_at": "2026-04-13T14:40:16+00:00", "published_display": "13 Apr 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron, Telix partner on radiopharmaceutical cancer therapies", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOV2ZUU0VibXZBVVN2UVRidmdBWXNId0M0VmFocGFMb1EtVzNYbHZKNlJoa1RYNkRINXowTGNDZGdWTWlsMmUzbXhKOG1zR0xGcDFZeEplazluakY5aS1raHZJXzBPRWNVNjRiN0l1RkpjYnhNOER1dEFzVFJsQnFxWU1wVGloT1JGbk0zTHVmNVQ5bkRmczN2YllaQVh3YXQ2Z093N2pDb0lJNml1TTdkTjVFYm9VLUpneHRYeg?oc=5", "source_name": "Investing.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piper Sandler reiterates Overweight rating on Regeneron stock at $875", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQU2FZTktJbjhsckFkeVBFZ2NsR2dPT05FX2EzcTlQR1pHdjJCY3BrOHZ5NEg1STNwMW03Y3lEbVFtMzJqaEdGcUVSdWhtdDZYa2ZxczJ0dDdxSkpPUWRuYS1XWlhvZXpBNmdKQWhRY3UwWGtmR2lTVnY4Z1U0R2tkbUZjX3NpYzdMeVU0aktXc1h6M0Y2S29rM1hpZ0ZQXzFTZV9wdF9wZkhtQTB5SGFHbFVhdlpVcjRBOTQ5dy1TU3VSSkRuRGFn?oc=5", "source_name": "Investing.com", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Today's Analyst Rating Update for Regeneron Pharmaceuticals (REG", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOVXdYVXhfZnEzTGdqdXZKNGREU0tyZW1pWmxUOHptRl92OHJ1blZUakhZZ2JQamJyenlHSUxFdTJjUThpcVBnUjhYV3EzQnRiTXNxQ0tsRDZ6SGtiTm16WUdSRTBlUENIcmt1Ym05UVBBR2NqcmRwQ3VQdlY1RkM3VmVnOExFV2xNMDBHbmF4OUQ0dzk0X3FWRUlCaUg0MlhONnU1QkgwU19UWXh0R0kxZGozZVNDRW5ialE?oc=5", "source_name": "GuruFocus", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bernstein SocGen lowers Regeneron stock price target on revenue mix shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNVnZNMTJxbmVIYktadFprTFdjLWpURUhQNnRZVXNhM2QxVHNFemx5akhqRlJlMFI0alFyQmgxeDZNZ3djUzlwODVaV2FVWC0zd0hXWGdzTFJwV1pGNVdQOVlRbm02WEVyZnIyVUw4NXdTWDE5X1k2TWVNY3hCcW1HaTdxM3JDZV84NjFnbS1YX3VydmVINTU2bkxJUEoyUXJJWGtBYlA2REVXRDgxdVlGZUdVM2V6bnBVcUs5Yk4wU1c2RlA1UW1MNlR4ZEFmdw?oc=5", "source_name": "Investing.com", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron (REGN) director Ryan sells $77,727 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOLU14MHZza2c2WTZBMHNwd3VuSVlKVnBFNW1fMk9xUnViYXU1bTZFMmkzRnh4RUYyQXFQN3ZodUFqMFJzMTdrRlNQR3dEVll0WmhkT0MyMDE5ZWJ2dC05dzVmYW5RX1hnUERUamtOcHotcGZ6MmQ1RnVQbThfMXR5eHZ2Y0NBVnBWYTlDUkFFM0NBaHhSWUZiV2lYX1Q4d2pjbFVqdm1NWkdzSkRvOVQ0SnlLUFc?oc=5", "source_name": "Investing.com", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPMk9vd0c5d2g3RkNrUmtuU3FBOGFlTDBoYXNHWDJOX1Zzc09vZk9jeEVBTVR5Yzl0RVIyM1V3Z0VFUHpmY0hNbTlHZ1QyeGFmMFNhTm5jd0tqbUVoN1JEMlpCQ0d1ZFA1dXl6Wnc0Qkw2Sl8wenR3QTRKaHZkal9tNm5fR05LQXgtQW1xemV2TVBMYU1KTTlFOHh5NFhfYzJiaHNxb2JnMA?oc=5", "source_name": "Barchart.com", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals stock hits 52-week high at $795.88", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPTG8xb0ZDY0ZNSmVjQ0RIZ3JVeGt5eUQ5ZnVzSl9kejZ2ZnRGdGtHQU1TNUx2QktoVC1kZ0FMZUYzTkI5OXBHWGxJVU5lalpNUHFyU1AyX3dWWlJDcDVHcVhOY3RIQ092MlJXRkJrVDJiRkxKQi1lZE5xSlQtaklSTHZ2RE9RWTByamZ1c3pFZUpYRGN1Y0M3d2Z6N3d5dDJ3dWZjelByaDdxUFI1TWdaYXIxM1Y?oc=5", "source_name": "Investing.com", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Cantor Fitzgerald reiterates Overweight on Regeneron stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQY3BSUG9mVG1DemtqN3h0UnNDWVhjZmlXbmpMTmJTejNNR2Q0YnZadlJadUVueHZZcGQ0bElZUnNCd3ZMU1UzbGlGVC1hd0FJRlFkMEVWVkFPbHJ2SlU5Xy1rTHBMV3FuU2hfZnBheHBja3Jpc2E0T1hjSnJ5MlZKLS0xbXE5QnJPMDhrWllKaHRRM1BPRGxCRXRlV0VpX2FOT3VkVmFFMnN5OE1xQW52MXJKVlN1clJXY2c?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T12:38:02+00:00", "published_display": "13 Jul 2026 12:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines closes $770.5m IPO, Regeneron investment By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPU0tSSk1jMzJOYU9ZUHQyaGRfUjR6OVJEaWlxUHBadXFFOXAxQ0RQTGZyM24wVExXS1A2dHhJUEdMNU5GekMyWXRwY1ZqSUpPcG94bS1yNkRvTUJMMGlqMFFzckZ1T1E0N1g5czV1NnpLaGlpZ29qN05PQVp1RDJrVWZpVU5EaTA1Uk53WTRVVE0zcE9Lb0NMUl9jTVpLdlVCM3FqREpKamZyNWJQdzMyWC03cnY?oc=5", "source_name": "Investing.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals Stock Underperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOX21uNnozSGduQ1M3QlRrWWNxZnZlWG1jMGRqOWtQZzUwcUhtZk5BOV9KWWQ0MFBXUG9NX0ZhSnF6TVd5OVktZmpOTUJqeUhFanNZYkpIYmdHY2Z1V3RLT3JOM21LUE1CU2xkZjJGcjViVzJ6MzBCLXdRekVYTjdoa0U2RlBOc1pLSmRfT1l5RDRfSVBVOEJPWWVwbDMyeFdMVkV6Mg?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxPaElEUnNfMXZSWlNUNHpSQzItbUJjY3I3M3lSSXc1LV8zLWpjcWY0Xzl3WjBmZUp4RThrdDRDZnNMc3JFNTJ4QWpHZHd3ZlRIcHpqTDNlRUZNNldfcWRJQi1yOGltZl9qSFdwcUNJT2p1NmlVQWdmNmQ5RUhIY3g4NERESVdkaV9CSUFjYUNVeDFxaG1CYnJzNFpDanFDb0E2NUFYS1VWYTFVWlhIVWhJOU1ma1hhclNocERGdDJnRjl6dEhkbGdlM2NPa1IzZnc3VDFJbGpaZXdSUlpJNDFzN2hIajVLcUFVQVg1cVZjQjg0eWN3eUdKbGN4TzlaVnU1WEE?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOeE1fSzB4M1VyMGNuay1rc1lEaDFBV19SS2dCZjFPdnpKX3RDSUFNM0tYdFdicXFXMVFmdFZyNmdYWjFfUTJ5T2M2SDlfSUdCQ3llMXNlSVZfeXFjNG05RnFRcmdsZ0NaV3ZUTlFnNl9DU2dqYVY3OS1SbGl2a0FKTW1rSFkyQjJlSFY1Y1c3anBNSnhIYktMR1NIdzFOam1HTzJxSmJuS2tQNG00R1Y0T1hKbG9MR3FCYTdwRW9NWi1rQzhTaWVMMVR3?oc=5", "source_name": "Barchart.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOdFFtWjBqUUZtY1JKVHVJczNUV0VsaUNsckR3cXY3SnlDbWlidlkzZ1RwNmR2LVpMM1FvdjZra2tvNVptS3JobG0zN0VvaHludjYtaW9waFplcHNXY0pCRFlpZ1NERWZjMjQwZUVJSWIydWlPZDZ6cEM1RkVlUmR5TDRUdmxmWWVOV3BXUkNVSWVyT050b09aRHFWWUF3d3hwTnVfYjUtYU8wM19pel9qTXVrTmhXaE5GU2FQeHVveldOVTdC?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron shares slide despite Q1 beat", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNSmUwR1RzVHZWRm01cUFQVGhJNU9EbDBIbHBvdDQyaUl1Z2lVSWtXZENKdWxpUHN5X1Q2bGM3VXkyS3lCcUZQRlZkRFFhSkhCMnJpLWFJQXNkYUhwaUlSdUdrNlN1ckdSbWtSSzNHanh6MGFKQWd2SDZudWxkclA5X0doU2tzd3h0ZjBvdzdEd240VzRib25SeVVsVHNfdlFJYWlPRjhfcXNFSWNvanc?oc=5", "source_name": "Proactive financial news", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Regeneron Q1 2026 beats estimates, stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNbW50aG5rWjFnY1Roa3ZuRTBnVDdnX2R4MjhnVU5Wc2VFX2JOX3dLLVBPOUFTbmxCOVBCdEluM1VfcFRFX05EUF9Nd3JsWVUzbVd1N3c1NE1Ma05JQkZIcklscExmaVRFTXRHME1sdTU3ZWhvU0xVdS1SZDgwVmoyT2E2Ui1iSUUwNHFIQ2haXzNza0luT2d2cmhRalh4RFpRcG5pY0Q3M2JvX2ZMcXoxcUlyYkFKNzE0dG1jMkVNR2oxNGc?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bernstein SocGen lowers Regeneron stock price target to $913", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQaEs3ZDdjaUZlUGpIbVZQQi1TNWpmeEhmRnRZSllTYnZJS0QxZ0luMmdlbmsydmYtdTJUeUpqTk1DX3Fnd2Q2YnE5THRoWlRuSWZBX3RmRG1razZxYnlmRzI3SUdEbWRCblhjZmhUUWNkb200WVFxa3ljTFBiTmYyZWxScjNac0h0OHFXUm9EcjVrT2NPMXA2UzhrQkhIT0hJMFFkZVFtRjJ1R0Rqd2VsMmNHLTI0c0dNTGVN?oc=5", "source_name": "Investing.com", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron wins FDA approval for first gene therapy for genetic hearing loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQRXRkLU93ajlCYTBxa1JQQ1RYdTZJVXBDNmpBcTNNYzBFYWthTzExNFN1b09DUTZSYWxNN19vQzFxREZzOXoydzhjd2dQd0ZONS03NHRaZVZyLUhxNXhMbnJYVUhyRW5YNmFIUnloNDdTOEpZdnNHTkZLZktxNHpwZ2ZyMklqWkxkOW93UWFTVlpnLXZWSjB0elNTdnZqMmoyVDMwUVFoZm1ZTVY3a3dOWXA4Q0lQVVUxYTVwM1RXc1dvSkxwX2c?oc=5", "source_name": "Reuters", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron and Telix Announce Strategic Radiopharma Collaboration", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQN3p0TC1TbVVxOTE5Vm5ZQ2FmU2plWktUencybFRzcG5oSm5leFloVWJvSk5ORzcxLWNqNWo2VUlsd24yNk9rQlZHeXBsSHJ6bWJacUJhM2VhcENaeGxEZnY5aHEtQlB0a3lWT242a3o2Z0V1REhqT2RWeHNqMHRiZXl1UW1SSmxrN2txLTdtalBzUkwwRlVkWWVzanQ4S2ZyWnVmQ3pUNmNuejd4RE1Zd0FuaERCVUl1bjE0Umd1b3FNcV9BUGFKTmJjVQ?oc=5", "source_name": "Regeneron", "published_at": "2026-04-13T14:40:16+00:00", "published_display": "13 Apr 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron, Telix partner on radiopharmaceutical cancer therapies", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOV2ZUU0VibXZBVVN2UVRidmdBWXNId0M0VmFocGFMb1EtVzNYbHZKNlJoa1RYNkRINXowTGNDZGdWTWlsMmUzbXhKOG1zR0xGcDFZeEplazluakY5aS1raHZJXzBPRWNVNjRiN0l1RkpjYnhNOER1dEFzVFJsQnFxWU1wVGloT1JGbk0zTHVmNVQ5bkRmczN2YllaQVh3YXQ2Z093N2pDb0lJNml1TTdkTjVFYm9VLUpneHRYeg?oc=5", "source_name": "Investing.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piper Sandler reiterates Overweight rating on Regeneron stock at $875", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQU2FZTktJbjhsckFkeVBFZ2NsR2dPT05FX2EzcTlQR1pHdjJCY3BrOHZ5NEg1STNwMW03Y3lEbVFtMzJqaEdGcUVSdWhtdDZYa2ZxczJ0dDdxSkpPUWRuYS1XWlhvZXpBNmdKQWhRY3UwWGtmR2lTVnY4Z1U0R2tkbUZjX3NpYzdMeVU0aktXc1h6M0Y2S29rM1hpZ0ZQXzFTZV9wdF9wZkhtQTB5SGFHbFVhdlpVcjRBOTQ5dy1TU3VSSkRuRGFn?oc=5", "source_name": "Investing.com", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Today's Analyst Rating Update for Regeneron Pharmaceuticals (REG", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOVXdYVXhfZnEzTGdqdXZKNGREU0tyZW1pWmxUOHptRl92OHJ1blZUakhZZ2JQamJyenlHSUxFdTJjUThpcVBnUjhYV3EzQnRiTXNxQ0tsRDZ6SGtiTm16WUdSRTBlUENIcmt1Ym05UVBBR2NqcmRwQ3VQdlY1RkM3VmVnOExFV2xNMDBHbmF4OUQ0dzk0X3FWRUlCaUg0MlhONnU1QkgwU19UWXh0R0kxZGozZVNDRW5ialE?oc=5", "source_name": "GuruFocus", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bernstein SocGen lowers Regeneron stock price target on revenue mix shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNVnZNMTJxbmVIYktadFprTFdjLWpURUhQNnRZVXNhM2QxVHNFemx5akhqRlJlMFI0alFyQmgxeDZNZ3djUzlwODVaV2FVWC0zd0hXWGdzTFJwV1pGNVdQOVlRbm02WEVyZnIyVUw4NXdTWDE5X1k2TWVNY3hCcW1HaTdxM3JDZV84NjFnbS1YX3VydmVINTU2bkxJUEoyUXJJWGtBYlA2REVXRDgxdVlGZUdVM2V6bnBVcUs5Yk4wU1c2RlA1UW1MNlR4ZEFmdw?oc=5", "source_name": "Investing.com", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron (REGN) director Ryan sells $77,727 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOLU14MHZza2c2WTZBMHNwd3VuSVlKVnBFNW1fMk9xUnViYXU1bTZFMmkzRnh4RUYyQXFQN3ZodUFqMFJzMTdrRlNQR3dEVll0WmhkT0MyMDE5ZWJ2dC05dzVmYW5RX1hnUERUamtOcHotcGZ6MmQ1RnVQbThfMXR5eHZ2Y0NBVnBWYTlDUkFFM0NBaHhSWUZiV2lYX1Q4d2pjbFVqdm1NWkdzSkRvOVQ0SnlLUFc?oc=5", "source_name": "Investing.com", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPMk9vd0c5d2g3RkNrUmtuU3FBOGFlTDBoYXNHWDJOX1Zzc09vZk9jeEVBTVR5Yzl0RVIyM1V3Z0VFUHpmY0hNbTlHZ1QyeGFmMFNhTm5jd0tqbUVoN1JEMlpCQ0d1ZFA1dXl6Wnc0Qkw2Sl8wenR3QTRKaHZkal9tNm5fR05LQXgtQW1xemV2TVBMYU1KTTlFOHh5NFhfYzJiaHNxb2JnMA?oc=5", "source_name": "Barchart.com", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals stock hits 52-week high at $795.88", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPTG8xb0ZDY0ZNSmVjQ0RIZ3JVeGt5eUQ5ZnVzSl9kejZ2ZnRGdGtHQU1TNUx2QktoVC1kZ0FMZUYzTkI5OXBHWGxJVU5lalpNUHFyU1AyX3dWWlJDcDVHcVhOY3RIQ092MlJXRkJrVDJiRkxKQi1lZE5xSlQtaklSTHZ2RE9RWTByamZ1c3pFZUpYRGN1Y0M3d2Z6N3d5dDJ3dWZjelByaDdxUFI1TWdaYXIxM1Y?oc=5", "source_name": "Investing.com", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 70, "total_relevant": 19, "sentiment_summary": {"positive": 4, "negative": 2, "neutral": 13, "score": 52, "total": 19, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.9, "count": 1}], "positive_events": 4, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 56.58, "latest_week": "2026-07-10", "one_week_move": -0.0, "four_week_move": 8.8, "twelve_week_move": -8.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.873611, "market_dynamics_buy_signal": false, "relative_strength": -12.638285, "fair_value_gap": -18.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.2417, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.0% over one week, +8.8% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 51, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Investing.com", "count": 9}, {"label": "Barchart.com", "count": 3}, {"label": "GuruFocus", "count": 2}, {"label": "PR Newswire", "count": 1}, {"label": "Proactive financial news", "count": 1}, {"label": "Market source", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Regeneron", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 19}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 3}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "19", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.0% over one week, +8.8% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Cantor Fitzgerald reiterates Overweight on Regeneron stock"}], "updated_at": "2026-07-17T16:05:40.370833+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}